| NCT01190839 | Janssen Biotech, Inc. | Crohn´s Disease | 2010-11 | PHASE3 |
| NCT03209232 | Schneider Children´s Medical Center, Israel | Ulcerative Colitis | 2018-04-16 | NA |
| NCT00230529 | Centocor, Inc. | Psoriasis | | PHASE2 |
| NCT05660746 | Children´s Hospital Medical Center, Cincinnati|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Janssen Scientific Affairs, LLC | Crohn Disease | 2023-07-01 | PHASE2|PHASE3 |
| NCT02743390 | University of Campinas, Brazil | Hypertension | 2015-03 | PHASE4 |
| NCT00096655 | Centocor, Inc. | Ulcerative Colitis | 2002-05 | PHASE3 |
| NCT00760435 | University of California, San Diego|Nationwide Children´s Hospital | Kawasaki Disease | 2009-03 | PHASE3 |
| NCT00325078 | National Institute of Allergy and Infectious Diseases (NIAID) | Chronic Granulomatous Disease|Crohn´S-like IBD|Inflammatory Bowel Disease (IBD) | 2006-05 | PHASE1|PHASE2 |
| NCT00304954 | National Eye Institute (NEI) | Age-Related Macular Degeneration|Choroidal Neovascularization | 2006-02 | PHASE2 |
| NCT01181765 | Janssen Inc. | Crohn´s Disease | 2012-06 | PHASE4 |
| NCT02994836 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Crohn´s Disease|Inflammatory Bowel Disease|Ulcerative Colitis | 2017-04-21 | PHASE4 |
| NCT01661257 | Samsung Medical Center | Crohn´s Disease | 2009-10 | PHASE3 |
| NCT00748826 | Merck Sharp & Dohme LLC | Arthritis, Rheumatoid | 2002-08 | |
| NCT00202852 | Merck Sharp & Dohme LLC | Arthritis, Rheumatoid | 2005-06-01 | PHASE3 |
| NCT06839820 | University Hospital, Akershus | Infliximab|Infusion|IBD (Inflammatory Bowel Disease)|Patient Satisfaction | 2025-02-01 | NA |
| NCT07297069 | Asian Institute of Gastroenterology, India | Acute Severe Ulcerative Colitis | 2026-01-01 | PHASE2 |
| NCT00818168 | Merck Sharp & Dohme LLC|Centocor, Inc. | Spondylitis, Ankylosing | 2003-07 | |
| NCT00958906 | Icahn School of Medicine at Mount Sinai | Uveitic Macular Edema|Intraocular Inflammation | 2009-08 | PHASE1|PHASE2 |
| NCT01971814 | University of California, San Francisco | Ulcerative Colitis (UC)|Inflammatory Bowel Disease | 2013-11 | PHASE1 |
| NCT01408810 | Grupo de Estudo da Doen?a Inflamatória Intestinal | Ulcerative Colitis | 2011-02 | PHASE4 |
| NCT00207714 | Centocor, Inc.|Centocor BV | Rheumatoid Arthritis | 2003-11 | PHASE2 |
| NCT03393247 | Sixth Affiliated Hospital, Sun Yat-sen University | Crohn Disease | 2017-06-01 | NA |
| NCT01706692 | Swiss Dermatology Network for Targeted Therapies | Psoriasis | 2011-02 | |
| NCT03221166 | IRCCS Burlo Garofolo|Centro di Riferimento Oncologico - Aviano|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Crohn Disease | 2018-02-27 | PHASE3 |
| NCT00207766 | Centocor, Inc. | Crohn Disease | 2000-06 | PHASE3 |
| NCT05313620 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Ulcerative Colitis|Thromboembolism | 2022-04-01 | PHASE4 |
| NCT07120152 | Erwin Dreesen|San Raffaele University Hospital, Italy|University of Liverpool|Hospital Universitario La Fe|University of Southampton|Samsung Medical Center | IBD - Inflammatory Bowel Disease|RA - Rheumatoid Arthritis | 2025-09-01 | |
| NCT04891991 | Cairo University | Rhegmatogenous Retinal Detachment|Proliferative Vitreoretinopathy|Retinal Detachment | 2021-11-26 | PHASE2 |
| NCT05813860 | Sixth Affiliated Hospital, Sun Yat-sen University | Crohn Disease|Infliximab | 2023-04-30 | PHASE4 |
| NCT04921670 | Cares, Kristen, M.D. | Inflammatory Bone Disease | 2021-03-12 | |
| NCT04898231 | University of California, San Diego|Children´s Hospital of Michigan | Multisystem Inflammatory Syndrome-Children | 2020-12-22 | PHASE2|PHASE3 |
| NCT06136546 | Massachusetts General Hospital | Depressive Disorder, Major|Inflammation | 2025-01-23 | PHASE2 |
| NCT06033469 | IRCCS Burlo Garofolo | Inflammatory Bowel Diseases | 2018-03-15 | |
| NCT07257068 | M.D. Anderson Cancer Center | Checkpoint Inhibitor|Pilot Study|Diabetes Melletus | 2026-04-14 | NA |
| NCT05280405 | IRCCS Burlo Garofolo | Inflammatory Bowel Diseases | 2022-03-09 | PHASE4 |
| NCT02937701 | Amgen | Arthritis, Rheumatoid | 2016-10-10 | PHASE3 |
| NCT00818272 | Merck Sharp & Dohme LLC|Centocor, Inc. | Crohn´s Disease | 2002-12 | |
| NCT06786507 | Helwan University | Ulcerative Colitis (UC) | 2025-05-15 | |
| NCT01927263 | Nichi-Iko Pharmaceutical Co., Ltd. | Rheumatoid Arthritis | 2013-07 | PHASE3 |
| NCT00094458 | Centocor Ortho Biotech Services, L.L.C.|Schering-Plough | Crohn Disease | 2005-03 | PHASE3 |
| NCT01793519 | Georgetown University|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|University of Maryland, Baltimore|Washington D.C. Veterans Affairs Medical Center|Medstar Health Research Institute|Patient-Centered Outcomes Research Institute|Arthritis and Pain Associates of PG County|Arthritis & Rheumatism Associates, P.C.|Rheumatology Associates of Baltimore, L.L.C.|The Arthritis Clinic of Northern Virginia, P.C.|Arthritis and Rheumatic Disease Associates, P.C. | Rheumatoid Arthritis | 2013-01 | PHASE4 |
| NCT04564001 | Assistance Publique - H?pitaux de Paris | Takayasu Arteritis | 2020-09 | PHASE2 |
| NCT02728934 | Janssen Scientific Affairs, LLC | Arthritis, Rheumatoid | 2016-02-25 | |
| NCT04974099 | Children´s Hospital Medical Center, Cincinnati|Crohn´s and Colitis Foundation | Crohn Disease | 2021-10-01 | PHASE2|PHASE3 |
| NCT00207688 | Janssen Research & Development, LLC|Janssen Biologics BV | Ulcerative Colitis | 2004-08-31 | |
| NCT00074074 | European Organisation for Research and Treatment of Cancer - EORTC | Myelodysplastic Syndromes | 2003-10 | PHASE2 |
| NCT00725296 | Merck Sharp & Dohme LLC|Centocor, Inc. | Arthritis, Psoriatic | 2004-12 | |
| NCT07491913 | Marmara University | Takayasu Arteritis | 2025-06-15 | NA |
| NCT00984568 | Merck Sharp & Dohme LLC | Colitis, Ulcerative | 2009-11 | PHASE3 |
| NCT00779012 | Merck Sharp & Dohme LLC | Spondylitis, Ankylosing | 2004-10-01 | PHASE4 |
| NCT00236028 | Centocor, Inc. | Rheumatoid Arthritis | | PHASE3 |
| NCT00283712 | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence | Pemphigus | 2006-03 | PHASE2 |
| NCT01812954 | Jochen Schmitt.|Merck Sharp & Dohme LLC | Psoriasis | 2013-03 | |
| NCT00368264 | Medical University of Vienna|Hospital Hietzing|Medical University of Graz|Charite University, Berlin, Germany|University of Erlangen-Nürnberg|Heinrich-Heine University, Duesseldorf|University Medical Center Groningen|Leiden University Medical Center|Radboud University Medical Center | Lupus Erythematosus, Systemic|Lupus Nephritis | 2006-09 | PHASE2|PHASE3 |
| NCT00571337 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | Crohn Disease | 2005-12 | PHASE3 |
| NCT02799615 | Children´s Hospital Medical Center, Cincinnati|Crohn´s and Colitis Foundation | Colitis, Ulcerative|Bowel Diseases, Inflammatory | 2016-05 | |
| NCT05180994 | Centre hospitalier de l´Université de Montréal (CHUM)|Fonds de recherche en ophtalmologie de l´Université de Montréal|Maisonneuve-Rosemont Hospital|Niagara Health System|Prism Eye Institute|Ottawa Hospital Research Institute | Glaucoma Following Surgery | 2022-05-01 | PHASE1|PHASE2 |
| NCT05931458 | Federico II University|Crohn´s and Colitis Foundation | Ulcerative Colitis | 2023-07-01 | NA |
| NCT02505568 | Janssen Korea, Ltd., Korea | Behcet Disease | 2015-07-22 | PHASE3 |
| NCT00202865 | Merck Sharp & Dohme LLC | Spondylitis, Ankylosing | 2005-05-01 | PHASE3 |
| NCT04305145 | Massachusetts General Hospital|Dana-Farber Cancer Institute | Melanoma Stage III|Melanoma Stage IV|Skin Cancer Stage III|Skin Cancer Stage IV|Drug-Induced Colitis|Drug Toxicity|Immune-related Adverse Event | 2020-08-31 | PHASE2 |
| NCT02136069 | Hoffmann-La Roche | Ulcerative Colitis | 2014-12-24 | PHASE3 |
| NCT00112749 | Jonsson Comprehensive Cancer Center|American Cancer Society, Inc. | Breast Cancer|Fatigue | 2005-02 | PHASE2 |
| NCT00106847 | Centocor, Inc. | Psoriasis|Parapsoriasis | 2003-01 | PHASE3 |
| NCT00269854 | Centocor, Inc. | Crohn Disease | 1995-06 | PHASE2|PHASE3 |
| NCT02298062 | Fudan University|Shanghai Children´s Medical Center|Shanghai 10th People´s Hospital|Shanghai 8th People´s Hospital|Shanghai Xuhui Distrct Center Hospital | Kawasaki Disease | 2013-01 | PHASE3 |
| NCT00439283 | Association de Recherche Clinique en Rhumatologie | Ankylosing Spondylitis | 2003-04 | PHASE3 |
| NCT00791557 | University Hospitals Cleveland Medical Center|Centocor, Inc. | Pyoderma Gangrenosum|Crohn´s Disease|Ulcerative Colitis|Inflammatory Bowel Disease | 2008-10 | NA |
| NCT00844805 | Merck Sharp & Dohme LLC | Ankylosing Spondylitis|Axial Spondyloarthritis | 2009-09 | PHASE3 |
| NCT00432432 | Chinese University of Hong Kong | Ankylosing Spondylitis | 2005-02 | PHASE4 |
| NCT04646187 | University Medical Center Groningen|European Crohn?s and Colitis Organisation|Bühlmann Laboratories AG | Inflammatory Bowel Diseases|Crohn Disease|Colitis, Ulcerative | 2021-03-11 | PHASE4 |
| NCT01266785 | Oregon Health and Science University|Centocor, Inc. | Crohn´s Disease | 2010-12 | NA |
| NCT02126020 | James Chodosh, MD, MPH|Massachusetts Eye and Ear Infirmary|Fonds de recherche en ophtalmologie de l´Université de Montréal | Stevens-Johnson Syndrome|Toxic Epidermal Necrolysis (Lyell) Syndrome|Mucous Membrane Pemphigoid | 2014-11 | PHASE1|PHASE2 |
| NCT00254982 | Merck Sharp & Dohme LLC|Essex Pharma GmbH|Centocor, Inc. | Psoriasis | 2005-08 | PHASE3 |
| NCT03445624 | Assiut University | Inflammatory Bowel Diseases | 2018-07-01 | |
| NCT00542152 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | Ulcerative Colitis|Steroid Refractory | 2007-06 | PHASE4 |
| NCT06941376 | University of Pennsylvania | Relapsing Polychondritis | 2025-08-01 | PHASE2 |
| NCT00795574 | Florida Academic Dermatology Centers | Hidradenitis Suppurativa | 2005-06 | PHASE2 |
| NCT03016260 | TcLand Expression S.A.|European Commission | RheumatoId Arthritis | 2016-12 | |
| NCT00036387 | Centocor, Inc. | Arthritis, Rheumatoid | | PHASE3 |
| NCT04779892 | Taizhou Mabtech Pharmaceutical Co.,Ltd | Rheumatoid Arthritis | 2020-02-01 | PHASE1 |
| NCT04835506 | Beth Israel Deaconess Medical Center|The Leona M. and Harry B. Helmsley Charitable Trust|Icahn School of Medicine at Mount Sinai | Crohn Disease|Ulcerative Colitis|Inflammatory Bowel Diseases | 2021-11-01 | PHASE4 |
| NCT03704363 | Oslo University Hospital|Haukeland University Hospital|St. Olavs Hospital|University Hospital of North Norway|Vestre Viken Hospital Trust|Ostfold Hospital Trust|Clinical Trial Unit (CTU), Oslo University Hospital|Diakonhjemmet Hospital | Low Back Pain | 2018-12-12 | PHASE3 |
| NCT04761952 | Sixth Affiliated Hospital, Sun Yat-sen University | Inflammatory Bowel Diseases|Crohn Disease|Polyunsaturated Acid Lipidosis | 2021-02-13 | NA |
| NCT01355614 | Novartis Pharmaceuticals | Crohn´s Disease | 2011-06 | PHASE2 |
| NCT05379049 | University of Sulaimani | Rheumatoid Arthritis|Inflammatory Arthritis|Ankylosing Spondylitis | 2022-03-01 | |
| NCT00705484 | Merck Sharp & Dohme LLC|Centocor, Inc. | Ulcerative Colitis | 2007-06-01 | |
| NCT05823532 | Emory University|National Institute of Mental Health (NIMH) | Schizophrenia | 2024-04-18 | PHASE4 |
| NCT03004443 | Emory University|National Institute of Mental Health (NIMH) | Depression | 2017-05-15 | PHASE4 |
| NCT02177071 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives|Saint-Louis Hospital, Paris, France | Crohn´s Disease | 2015-10-09 | PHASE4 |
| NCT05168475 | Cambridge University Hospitals NHS Foundation Trust | Giant Cell Arteritis|Takayasu Arteritis|Cogan Syndrome|Relapsing Polychondritis|Cryoglobulinemic Vasculitis|IgA Vasculitis|Polyarteritis Nodosa|Cutaneous Polyarteritis Nodosa|Primary Angiitis of Central Nervous System | 2021-07-14 | PHASE2 |
| NCT05928039 | University of Calgary|Alimentiv Inc. | Crohn Disease | 2023-10-25 | PHASE4 |
| NCT00252369 | Sheba Medical Center | Crohn´s Disease | | NA |
| NCT00505947 | University of Athens | Diabetic Macular Edema|Visual Acuity|Diabetic Retinopathy | 2007-07 | PHASE3 |
| NCT00237484 | Merck Sharp & Dohme LLC | Hepatitis C, Chronic | 2005-07-18 | PHASE3 |
| NCT05906576 | Taizhou Mabtech Pharmaceutical Co.,Ltd | Crohn Disease | 2023-09-21 | PHASE4 |
| NCT00808210 | Genentech, Inc. | Rheumatoid Arthritis | 2009-03-05 | PHASE2 |
| NCT02770040 | Austin Health|University of Melbourne | Ulcerative Colitis | 2016-07-18 | PHASE4 |
| NCT05552287 | Erasmus Medical Center | Crohn Disease|Child, Only|Biologic; Inadequate | 2023-08-02 | PHASE4 |
| NCT00604864 | KU Leuven | Endometriosis | 2004-02 | PHASE2 |
| NCT03452501 | Hikma Pharmaceuticals LLC | Inflammatory Bowel Diseases|Crohn Disease|Fistulizing Crohn´s Disease|Ulcerative Colitis | 2018-08-26 | |
| NCT00336492 | Centocor, Inc. | Ulcerative Colitis | 2006-09 | PHASE3 |
| NCT03885037 | Pfizer | Rheumatoid Arthritis | 2019-03-20 | |
| NCT00749398 | Merck Sharp & Dohme LLC | Psoriasis | 2007-09 | |
| NCT02222493 | Pfizer | Rheumatoid Arthritis | 2014-08-26 | PHASE3 |
| NCT00133315 | Hvidovre University Hospital | Spondylarthropathies|Ankylosing Spondylitis|Psoriatic Arthritis | 2004-09 | PHASE4 |
| NCT02847884 | University of Alberta|The Hospital for Sick Children|The Children´s Hospital of Winnipeg|Alberta Children´s Hospital|Provincial Health Services Authority British Columbia|Children´s Hospital of Eastern Ontario | Inflammatory Bowel Disease|Crohn´s Disease | 2015-10 | |
| NCT05340764 | Washington University School of Medicine | Inflammatory Bowel Diseases | 2020-08-01 | PHASE4 |
| NCT00317538 | Centocor Ortho Biotech Services, L.L.C. | Rheumatoid Arthritis | 2003-06 | PHASE3 |
| NCT02363738 | University Health Network, Toronto|Clinical Investigation Centre for Innovative Technology Network|Stanford University | Bipolar Depression | 2015-09 | PHASE2 |
| NCT00095147 | Bristol-Myers Squibb | Rheumatoid Arthritis | 2005-02 | PHASE3 |
| NCT00216177 | Hvidovre University Hospital|University Hospital, Gentofte, Copenhagen | Rheumatoid Arthritis | 2005-09 | PHASE4 |
| NCT04922827 | Jena University Hospital|German Federal Ministry of Education and Research|Celltrion | COVID-19 | 2021-06-18 | PHASE2 |
| NCT04150770 | Xiaomin Zhang | Uveitis|Infliximab | 2017-01 | PHASE4 |
| NCT05530122 | Tampere University Hospital | Ulcerative Colitis | 2009-01 | |
| NCT05291039 | Rehab Werida | Inflammatory Bowel Diseases | 2022-01-01 | NA |
| NCT03100253 | Mario Negri Institute for Pharmacological Research | Rheumatoid Arthritis | 2018-03-01 | PHASE4 |
| NCT01915537 | Zhang, Xiao, M.D.|Central South University|Tianjin Medical University General Hospital|Xijing Hospital | Rheumatoid Arthritis?RA? | 2013-08 | NA |
| NCT02878161 | Fen Li | Rheumatoid Arthritis | 2016-01 | PHASE4 |
| NCT01233583 | University of Aberdeen|NHS Grampian | Psoriasis | 2010-06 | |
| NCT02763761 | Bristol-Myers Squibb | Renal Cell Carcinoma|Melanoma|Lung Cancer | 2016-08-16 | PHASE2 |
| NCT00029042 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Juvenile Rheumatoid Arthritis | 2002-01 | PHASE2 |
| NCT02148640 | Diakonhjemmet Hospital|South-Eastern Norway Regional Health Authority | Rheumatoid Arthritis|Spondyloarthritis|Psoriatic Arthritis|Ulcerative Colitis|Crohn´s Disease|Psoriasis Chronic | 2014-10 | PHASE4 |
| NCT01308255 | University of Leeds | Rheumatoid Arthritis | 2006-09 | PHASE4 |
| NCT00246064 | Centocor Ortho Biotech Services, L.L.C. | Arthritis, Rheumatoid | 2001-12 | PHASE4 |
| NCT01015547 | Helsinki University Central Hospital|Foundation for Paediatric Research, Finland|P?ivikki and Sakari Sohlberg Foundation, Finland|Rheumatism Foundation Hospital|Scandinavian Rheumatology Research Foundation|Paijat-Hame Hospital District | Juvenile Idiopathic Arthritis | 2003-05 | PHASE3 |
| NCT00688636 | University of Pittsburgh|Centocor, Inc. | Crohn´s Disease | 2005-01 | PHASE4 |
| NCT00901550 | Chinese University of Hong Kong | Rheumatoid Arthritis | 2008-11 | NA |
| NCT01349920 | Merck Sharp & Dohme LLC | Crohn Disease | 2012-11-28 | |
| NCT01485055 | Nationwide Children´s Hospital | Graft Versus Host Disease|Steroid Refractory GVHD|Acute GVH Disease | 2011-12 | PHASE2 |
| NCT00073437 | Centocor, Inc. | Sarcoidosis | 2003-10 | PHASE3 |
| NCT07176754 | Peking University Third Hospital|Peking University First Hospital|Peking University People´s Hospital|Peking University Shenzhen Hospital|Qilu Hospital of Shandong University|Jiangsu Provincial People´s Hospital|Hunan Provincial People´s Hospital|Sichuan Provincial People´s Hospital|People´s Hospital of Guangxi Zhuang Autonomous Region|People´s Hospital of Xinjiang Uygur Autonomous Region|Renmin Hospital of Wuhan University | Cardiac Arrest (CA)|Post Cardiac Arrest Syndrome | 2025-10-01 | NA |
| NCT02638701 | University of California, San Francisco | Aneurysm|Stroke|Vasculitis|Tumor Necrosis Factor-alpha | 2024-10-01 | PHASE1|PHASE2 |
| NCT02332356 | Tokyo Medical and Dental University | Crohn Disease | 2014-09 | PHASE3 |
| NCT00106834 | Centocor, Inc. | Psoriasis | | PHASE3 |
| NCT05912712 | Xijing Hospital of Digestive Diseases | Ulcerative Colitis Chronic Moderate|Ulcerative Colitis Chronic Severe|Rectal Ulcer | 2023-07-01 | PHASE1 |
| NCT00358670 | Merck Sharp & Dohme LLC | Psoriasis | 2006-05 | PHASE3 |
| NCT07352566 | University of California, San Francisco | Psoriasis|Atopic Dermatitis | 2026-01-01 | PHASE4 |
| NCT03006393 | Emory University|National Institute of Mental Health (NIMH) | Depression | 2016-08 | PHASE4 |
| NCT07576452 | University Hospital, Clermont-Ferrand|Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | Ulcerative Colitis (UC) | 2026-06-01 | PHASE4 |
| NCT00521963 | HaEmek Medical Center, Israel|Bnai Zion Medical Center|Carmel Medical Center | Arthritis | 2010-03 | PHASE2|PHASE3 |
| NCT03293784 | Institut Claudius Regaud | Melanoma | 2017-10-16 | PHASE1 |
| NCT06269185 | Vastra Gotaland Region | Ulcerative Colitis|Inflammatory Bowel Diseases | 2024-03-06 | |
| NCT00686595 | Merck Sharp & Dohme LLC|Centocor, Inc. | Psoriasis | 2007-10-01 | PHASE4 |
| NCT00936143 | Gu Jieruo | Spondylitis | 2008-01 | PHASE4 |
| NCT00725543 | Merck Sharp & Dohme LLC|Centocor, Inc. | Spondylitis, Ankylosing | 2004-06 | |
| NCT00076726 | Centocor, Inc.|The Cleveland Clinic | Giant Cell Arteritis | 2003-11 | PHASE2 |
| NCT01931189 | Nichi-Iko Pharmaceutical Co., Ltd. | Healthy | 2013-08 | PHASE1 |
| NCT05386290 | Peking Union Medical College Hospital | Ulcerative Colitis|Crohn Disease | 2020-07-09 | |
| NCT00237419 | Rheumazentrum Ruhrgebiet|Centocor BV|Trial Coordination Center, 9713 GZ Groningen|PPD Development, LP | Ankylosing Spondylitis | 2005-12 | NA |
| NCT02132234 | Jagiellonian University|Departmet of Rheumatology, J Dietl Hospital, Krakow, Poland | Rheumatoid Arthritis|Psoriatic Arthritis|Ankylosing Spondylitis|Hypertension | 2013-06 | PHASE4 |
| NCT00261976 | Centocor, Inc.|Centocor BV | Arthritis, Rheumatoid|Crohn Disease|Psoriasis | 2002-02 | |
| NCT00959725 | Icahn School of Medicine at Mount Sinai | Diabetic Macular Edema | 2009-08 | PHASE1|PHASE2 |
| NCT00574470 | University of Iowa | Graft vs Host Disease | 2006-01 | PHASE4 |
| NCT00752622 | Merck Sharp & Dohme LLC | Crohn´s Disease | 2008-11 | PHASE4 |
| NCT00589628 | Egla C. Rabinovich|Childhood Arthritis and Rheumatology Research Alliance | Chronic Uveitis | 2007-09 | PHASE4 |
| NCT00432406 | Chinese University of Hong Kong | Psoriatic Arthritis | 2006-05 | PHASE4 |
| NCT00367237 | Merck Sharp & Dohme LLC|Integrated Therapeutics Group | Arthritis, Psoriatic | 2006-05 | PHASE3 |
| NCT00244179 | Charite University, Berlin, Germany|dfg | Reactive Arthritis | 2003-01 | PHASE2 |
| NCT00396747 | Université Catholique de Louvain | Rheumatoid Arthritis | 2003-06 | PHASE4 |
| NCT06646016 | Therakos LLC | Immune-related Colitis | 2025-12-15 | PHASE2 |
| NCT04312659 | Johnson & Johnson (China) Investment Ltd. | Crohn Disease | 2020-07-15 | |
| NCT05947669 | Odense University Hospital|Aalborg University Hospital|Royal Marsden NHS Foundation Trust | Colitis | 2023-08-22 | PHASE3 |
| NCT03937609 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Pfizer | Colitis, Ulcerative | 2019-09-04 | PHASE4 |
| NCT00897312 | Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) | Melanoma | 2006-10 | |
| NCT01313520 | Merck Sharp & Dohme LLC | Arthritis, Rheumatoid | 2011-03-01 | PHASE2 |
| NCT00051623 | Centocor, Inc. | Arthritis, Psoriatic | 2003-05 | PHASE3 |
| NCT00823641 | Imperial College London|Medical Research Council | HTLV-I-associated Myelopathy | 2008-10 | PHASE2 |
| NCT05043870 | Children´s Hospital of Fudan University | Crohn Disease|Infliximab|Immunosuppression|Children, Only | 2022-10-10 | PHASE4 |
| NCT07510191 | Sixth Affiliated Hospital, Sun Yat-sen University | Crohn Disease (CD) | 2026-03-01 | PHASE4 |
| NCT06113913 | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW|Celltrion | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis | 2024-04-09 | PHASE4 |
| NCT00111917 | Maier, Lisa, M.D.|Centocor, Inc.|National Center for Research Resources (NCRR) | Berylliosis|Beryllium Disease | 2005-02 | PHASE1|PHASE2 |
| NCT02517684 | Erasmus Medical Center|ZonMw: The Netherlands Organisation for Health Research and Development|Hospira, now a wholly owned subsidiary of Pfizer | Crohn´s Disease | 2015-04 | PHASE4 |
| NCT01571206 | Celltrion | Ankylosing Spondylitis | 2012-03 | PHASE1 |
| NCT00896168 | Xian-Janssen Pharmaceutical Ltd. | Arthritis, Rheumatoid | 2007-06 | PHASE4 |
| NCT00695682 | Retina Research Foundation | Diabetic Retinopathy|Macular Degeneration | 2008-06 | PHASE1 |
| NCT01245361 | Patrick Durez | Undifferentiated Arthritis | 2007-11 | NA |
| NCT01216631 | University of Leeds|Centocor, Inc. | Spondylarthropathies | 2010-09 | PHASE2 |
| NCT03596645 | Janssen Research & Development, LLC | Colitis, Ulcerative | 2018-10-29 | PHASE3 |
| NCT01602302 | Medical University of Graz | Rheumatoid Arthritis | 2012-06 | PHASE4 |
| NCT03884439 | Pfizer | Crohn´s Disease|Ulcerative Colitis | 2019-03-18 | |
| NCT01282528 | Peking Union Medical College Hospital|Shanghai Changzheng Hospital|First Hospital of China Medical University|Shenzhen People´s Hospital|Changhai Hospital|First Affiliated Hospital of Wenzhou Medical University|First People´s Hospital of Foshan|West China Hospital | Rheumatoid Arthritis|Ultrasonography|Infliximab | 2010-09 | PHASE4 |
| NCT05034536 | Massachusetts General Hospital|Massachusetts Institute of Technology | Metastatic Melanoma | 2022-02-07 | PHASE2 |
| NCT00727298 | Merck Sharp & Dohme LLC|Centocor, Inc. | Arthritis, Rheumatoid|Spondylitis, Ankylosing|Arthritis, Psoriatic|Psoriasis|Crohn´s Disease | 2006-02 | |
| NCT00251641 | Merck Sharp & Dohme LLC | Psoriasis | 2005-09-01 | PHASE3 |
| NCT00753103 | University Hospital Birmingham NHS Foundation Trust | Wegener´s Granulomatosis|Renal Limited Vasculitis|Microscopic Polyangiitis | 2003-01 | PHASE2 |
| NCT02453776 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Inflammatory Bowel Disease | 2015-05 | PHASE4 |
| NCT02566889 | Janssen Scientific Affairs, LLC | Inflammatory Bowel Diseases | 2016-04 | PHASE4 |
| NCT05072782 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives|Celltrion | Crohn Disease | 2021-12-21 | PHASE4 |
| NCT01551290 | Xian-Janssen Pharmaceutical Ltd. | Ulcerative Colitis | 2012-04 | PHASE3 |
| NCT00512278 | Nizar Zein|Centocor, Inc. | Hepatitis C | 2007-07 | PHASE2 |
| NCT04593940 | Daniel Benjamin|National Center for Advancing Translational Sciences (NCATS)|Biomedical Advanced Research and Development Authority | Covid19 | 2020-10-15 | PHASE3 |
| NCT01936181 | Samsung Bioepis Co., Ltd. | Rheumatoid Arthritis | 2013-08 | PHASE3 |
| NCT00244192 | Center for Integrated Rehabilitation and Organ Failure Horn|Centocor, Inc. | COPD|Cachexia | 2003-10 | PHASE2 |
| NCT02694588 | University Hospital Schleswig-Holstein | IBD | 2014-06 | NA |
| NCT03704610 | Assistance Publique - H?pitaux de Paris | Extrathoracic Sarcoidosis | 2019-03-28 | PHASE3 |
| NCT04775732 | Imelda GI Clinical Research Center | Crohn Disease|Ulcerative Colitis | 2018-06-01 | PHASE4 |
| NCT00741104 | Merck Sharp & Dohme LLC | Rheumatoid Arthritis | 2008-01 | |
| NCT00175266 | University of Alberta|Juvenile Diabetes Research Foundation | Type 1 Diabetes | | PHASE2 |
| NCT00207662 | Centocor, Inc. | Crohn Disease | 2000-07 | PHASE3 |
| NCT02998827 | Sixth Affiliated Hospital, Sun Yat-sen University | Crohn Disease | 2016-11 | NA |
| NCT04530877 | Children´s Hospital of Fudan University | Crohn´s Disease|Exclusive Enteral Nutrition|Infliximab|Mucosal Healing | 2022-10-01 | PHASE4 |
| NCT01804166 | Janssen Scientific Affairs, LLC | Hepatosplenic T-Cell Lymphoma | 2013-03-21 | PHASE4 |
| NCT02770794 | Chiba University | Arthritis, Rheumatoid | 2016-04-01 | PHASE4 |
| NCT00075075 | National Eye Institute (NEI) | Scleritis | 2003-12-23 | PHASE1 |
| NCT06059989 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Celltrion | Inflammatory Disease|Disease Crohn|Bowel Disease | 2021-11-25 | PHASE3 |
| NCT04999228 | Children´s Hospital of Fudan University | Ulcerative Colitis|Infliximab|Children | 2021-11-01 | PHASE4 |
| NCT03065244 | University of California, San Diego|Patient-Centered Outcomes Research Institute | Mucocutaneous Lymph Node Syndrome | 2017-02-17 | PHASE3 |
| NCT07138898 | NYU Langone Health | Rheumatic Disease | 2025-09 | PHASE2 |
| NCT03662919 | Biogen | Arthritis, Rheumatoid|Spondylitis, Ankylosing|Arthritis, Psoriatic|Crohn´s Disease|Colitis, Ulcerative | 2018-07-02 | |
| NCT03414502 | University of Nebraska | Rheumatoid Arthritis | 2007-12-10 | PHASE3 |
| NCT03043677 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Disease | 2016-04-01 | |
| NCT00606346 | Janssen Biotech, Inc. | Crohn´s Disease|Ulcerative Colitis|Indeterminate Colitis|Inflammatory Bowel Diseases | 2007-05-31 | |
| NCT07415473 | Chinese Medical Association|First Affiliated Hospital, Sun Yat-Sen University|Sixth Affiliated Hospital, Sun Yat-sen University|Shenzhen University General Hospital | Crohn´s Diseases | 2026-04-01 | PHASE4 |
| NCT00686894 | Merck Sharp & Dohme LLC|Centocor, Inc. | Spondylitis, Ankylosing|SpA | 2008-01 | PHASE4 |
| NCT06051253 | Asan Medical Center | Crohn Disease|Infliximab|Perianal Fistula Due to Crohn´s Disease|Therapeutic Drug Monitoring|Magnetic Resonance Novel Index for Fistula Imaging in Crohn´s Disease Score | 2023-11-01 | PHASE4 |
| NCT01442025 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | Crohn´s Disease | 2012-06 | PHASE4 |
| NCT04725422 | Seattle Children´s Hospital|Boston Children´s Hospital, Boston, MA, USA|Hospital for Special Surgery, New York|Joseph M Sanzari Children´s Hospital, Hackensack University Medical Center, Hackensack, NJ, USA|Riley Children´s Hospital, Indianapolis, IN, USA|University of North Carolina, Chapel Hill, NC, USA|Royal Children´s Hospital|Hacettepe University|Bambino Gesù Children´s Hospital, Rome, Italy|University of British Columbia, Vancouver, BC, Canada|Meyer Children´s Hospital, Florence, Italy|Mansoura University|University of Utah, Salt Lake City, UT, USA|University of Iowa Carver College of Medicine, Iowa City, IA, USA|Ann & Robert H Lurie Children´s Hospital of Chicago|Palacky University Olomouc Institute of Molecular and Translational Medicine, Olomouc, Czechia|Alder Hey Children´s NHS Foundation Trust|University of Calgary | Chronic Nonbacterial Osteomyelitis|Chronic Recurrent Multifocal Osteomyelitis | 2018-08-01 | |
| NCT03371095 | Assistance Publique - H?pitaux de Paris | Behcet´s Disease|Vasculitis | 2018-05-25 | PHASE3 |
| NCT04438382 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI) | Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Steroid-Refractory Pneumonitis | 2021-01-07 | PHASE2 |
| NCT00908089 | University of Helsinki|Seinajoki Central Hospital|Oulu University Hospital|Jyv?skyl? Central Hospital|Kuopio University Hospital|Satakunta Central Hospital|University of Turku|Rheumatism Foundation Hospital|Orton Invalid Foundation|South Carelia Central Hospital|Lappi Central Hospital|Kanta-H?me Central Hospital | Rheumatoid Arthritis | 2003-03 | PHASE4 |
| NCT03088293 | Hospices Civils de Lyon | Idiopathic Refractory Scleritis | 2020-06-11 | PHASE3 |
| NCT00521924 | Merck Sharp & Dohme LLC|AESCA Pharma GmbH | Rheumatoid Arthritis | 2007-06 | PHASE3 |
| NCT04330690 | Sunnybrook Health Sciences Centre|AbbVie|Apotex Inc.|World Health Organization|University of British Columbia|Arch Biopartners Inc. | COVID-19 | 2020-03-18 | PHASE3 |
| NCT04131504 | Children´s Hospital Medical Center, Cincinnati|The Leona M. and Harry B. Helmsley Charitable Trust | Crohn´s Disease|IBD | 2019-10-16 | |
| NCT04205643 | Celltrion | Ulcerative Colitis | 2020-09-01 | PHASE3 |
| NCT00796250 | Merck Sharp & Dohme LLC | Crohn´s Disease | 2003-11-01 | PHASE3 |
| NCT00006292 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Rheumatoid Arthritis | 2000-09 | PHASE2 |
| NCT00269867 | Centocor, Inc. | Rheumatoid Arthritis | 1997-03 | PHASE3 |
| NCT02088944 | Nanfang Hospital, Southern Medical University | Serological C Reactive Protein or Erythrocyte Sedimentation Rate | 2014-03 | |
| NCT05406934 | Assiut University | Bowel Disease|Inflammatory Bowel Diseases | 2022-06-05 | |
| NCT04407247 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Colitis|Lung Non-Small Cell Carcinoma|Malignant Genitourinary System Neoplasm|Malignant Solid Neoplasm|Melanoma | 2020-07-09 | PHASE1|PHASE2 |
| NCT00036374 | Centocor, Inc. | Rheumatoid Arthritis, Juvenile | 2001-10 | PHASE3 |
| NCT06453317 | Medical University of Lodz|Poznan University of Medical Sciences|Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Pozna?|Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz|Medical Research Agency, Poland | Ulcerative Colitis|Inflammatory Bowel Diseases | 2025-02-17 | PHASE2 |
| NCT01423591 | Hospital Universitario Marqués de Valdecilla|Schering-Plough | Polymyalgia Rheumatica | 2007-06 | PHASE3 |
| NCT01657513 | University Hospital, Gentofte, Copenhagen|The Michaelsen Foundation|Pfizer | Psoriasis | 2012-06 | NA |
| NCT03885713 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis | 2019-09-10 | PHASE4 |
| NCT01850121 | G?teborg University | Ankylosing Spondylitis | 2003-01 | |
| NCT03765450 | Alimentiv Inc. | Ulcerative Colitis | 2018-12-21 | |
| NCT00394589 | Merck Sharp & Dohme LLC|Integrated Therapeutics Group | Rheumatoid Arthritis | 2006-03 | PHASE3 |
| NCT04082910 | Chinese PLA General Hospital | Solid Tumor|Hematological Malignancy | 2019-09-15 | PHASE1|PHASE2 |
| NCT01559142 | Children´s Memorial Health Institute, Poland | Crohn Disease | 2008-11 | PHASE3 |
| NCT00988832 | Merck Sharp & Dohme LLC | Crohn´s Disease | 2010-02 | |
| NCT00724958 | Merck Sharp & Dohme LLC|Centocor, Inc. | Crohn´s Disease | 2004-12 | |
| NCT05164198 | Hanyang University Seoul Hospital|Linical Korea | Ankylosing Spondylitis|Axial Spondyloarthritis | 2022-01-15 | PHASE4 |
| NCT04990258 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives|Celltrion | Inflammatory Bowel Diseases | 2021-09-06 | |
| NCT00213564 | University Hospital, Rouen | Rheumatoid Arthritis | 2003-04 | |
| NCT00523354 | Swiss EE Study Group | Esophagitis | 2007-08 | PHASE2 |
| NCT00514982 | National Institute of Allergy and Infectious Diseases (NIAID) | Hermanski-Pudlak Syndrome|Colitis|Cytokines|Lymphocytes|Drug Evaluation | 2007-08-07 | PHASE2 |
| NCT05205603 | Sixth Affiliated Hospital, Sun Yat-sen University | Ulcerative Colitis|Efficacy, Self|Biologics|Mesalazine | 2022-01-15 | PHASE4 |
| NCT00687362 | Merck Sharp & Dohme LLC | Psoriasis | 2006-05-30 | PHASE2 |
| NCT02060318 | Hvidovre University Hospital | Crohn Disease | 2014-02-11 | |
| NCT04535518 | Children´s Hospital of Fudan University|Shanghai Children´s Hospital|Shanghai Children´s Medical Center|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Shanghai 10th People´s Hospital | Kawasaki Disease | 2020-10 | PHASE3 |
| NCT04734678 | Ain Shams University|Misr International University | Covid19|Cytokine Storm|Corona Virus Infection | 2020-12-01 | |
| NCT00273390 | Oregon Health and Science University|Centocor, Inc. | Uveitis | 2001-08 | NA |
| NCT04115423 | Sungkyunkwan University|Ministry of Food and Drug Safety, Korea | Infection|Rheumatoid Arthritis | 2020-04-01 | |
| NCT00463580 | Emory University|National Institute of Mental Health (NIMH) | Depression | 2008-12 | PHASE4 |
| NCT00705289 | Merck Sharp & Dohme LLC | Rheumatoid Arthritis | 2005-12 | |
| NCT02425852 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | Ulcerative Colitis | 2016-12 | PHASE4 |
| NCT00040885 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Anorexia|Cachexia|Fatigue|Lung Cancer | 2002-10 | PHASE3 |
| NCT02771457 | NYU Langone Health | Inflammatory Bowel Disease | 2016-07 | PHASE3 |
| NCT00207701 | Centocor, Inc.|Centocor BV | Ankylosing Spondylitis | 2002-09 | PHASE3 |
| NCT03684278 | University of Liverpool|Bangor University|Liverpool University Hospitals NHS Foundation Trust|Medical Research Council|National Institute for Health Research, United Kingdom|Merck Sharp & Dohme LLC | Acute Pancreatitis | 2019-05-01 | PHASE2 |
| NCT00207675 | Centocor, Inc.|Centocor BV | Crohn Disease | 2003-02 | PHASE3 |
| NCT01237262 | University of Padova | Moderate to Severe Psoriasis.|Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern. | 2010-11 | PHASE4 |
| NCT02073526 | Oslo University Hospital | Inflammatory Bowel Disease|Crohn´s Disease|Ulcerative Colitis | 2013-05 | |
| NCT02453607 | Ernest Seidman|University of Toronto|University of Calgary|University of Alberta | Inflammatory Bowel Disease|Crohn´s Disease | 2014-11-17 | |
| NCT01220518 | Celltrion | Ankylosing Spondylitis | 2010-10 | PHASE1 |
| NCT07424040 | The Children´s Hospital of Zhejiang University School of Medicine|Second Affiliated Hospital of Wenzhou Medical University|The First People´s Hospital of Yunnan | Crohn´s Diseases|Crohn´s Disease in Pediatric Patient | 2026-03-01 | NA |
| NCT01177800 | Xian-Janssen Pharmaceutical Ltd. | Psoriasis | 2009-02 | PHASE3 |
| NCT05584228 | Nantes University Hospital|Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | Crohn Disease | 2023-04-01 | NA |
| NCT00724243 | Merck Sharp & Dohme LLC | Rheumatoid Arthritis | 2006-01 | |
| NCT04655729 | Massachusetts General Hospital|Crohn´s and Colitis Foundation | Crohn Disease | 2019-11-18 | |
| NCT03151525 | Istituto Clinico Humanitas|Agenzia Italiana del Farmaco | Colitis, Ulcerative | 2017-05-08 | PHASE4 |
| NCT01000441 | University Hospital, Strasbourg, France | Rheumatoid Arthritis | 2009-12-23 | PHASE4 |
| NCT02987686 | Centre hospitalier de l´Université de Montréal (CHUM) | Sterile Corneal Melt | 2017-09-06 | PHASE1 |
| NCT00724529 | Janssen Korea, Ltd., Korea | Crohn´s Disease|Ankylosing Spondylitis | 2007-06 | |
| NCT03945019 | Celltrion | Crohn´s Disease | 2019-10-28 | PHASE3 |
| NCT06614387 | JAROSLAW KIERKUS | Ulcerative Colitis | 2024-10-01 | PHASE3 |
| NCT04879966 | Sixth Affiliated Hospital, Sun Yat-sen University | Moderate to Severe Ulcerative Colitis | 2021-05-17 | |
| NCT00724672 | Merck Sharp & Dohme LLC | Rheumatoid Arthritis | 2008-09 | |
| NCT00629772 | Innovaderm Research Inc.|Schering-Plough | Palmoplantar Psoriasis | 2007-03 | PHASE3 |
| NCT02322008 | Regionshospitalet Viborg, Skive | Crohn´s Disease|Ulcerative Colitis|Inflammatory Bowel Disease | 2009-09 | |
| NCT04610476 | University of Erlangen-Nürnberg Medical School | Psoriatic Arthritis|Withdrawal|Reduction | 2020-10-19 | PHASE3 |
| NCT03370601 | University Hospital, Lille | Inflammatory Bowel Diseases | 2017-01-03 | NA |
| NCT04178850 | Genor Biopharma Co., Ltd. | Rheumatoid Arthritis | 2017-10-13 | PHASE3 |
| NCT00307593 | Assistance Publique - H?pitaux de Paris | Wegener´s Granulomatosis|Churg-Strauss Syndrome|Microscopic Polyangiitis | 2004-05 | NA |
| NCT00686686 | Merck Sharp & Dohme LLC|Centocor, Inc. | Psoriasis | 2007-12 | PHASE3 |
| NCT06758024 | Pontificia Universidad Catolica de Chile|Clínica Universidad de los Andes|Hospital San Juan de Dios,Chile|University of Chile|Clinica Indisa|Universidad de La Frontera | Inflammatory Bowel Disease (IBD)|Crohn Disease (CD)|Ulcerative Colitis (UC) | 2025-01-24 | NA |
| NCT03112603 | Incyte Corporation | Graft-versus-host Disease (GVHD) | 2017-06-29 | PHASE3 |
| NCT07417696 | Chinese Medical Association|First Affiliated Hospital, Sun Yat-Sen University|Sixth Affiliated Hospital, Sun Yat-sen University|Shenzhen University General Hospital | Crohn´s Disease | 2026-04-01 | PHASE4 |
| NCT01817426 | Copenhagen University Hospital at Herlev | Crohn Disease | 2013-01 | PHASE4 |
| NCT02620618 | Cairo University | Beh?et´s Disease|Uveitis | 2013-01 | PHASE1|PHASE2 |
| NCT01256489 | Massachusetts Eye and Ear Infirmary | Stevens-Johnson Syndrome|Corneal Blindness | 2010-12 | PHASE1|PHASE2 |
| NCT04982172 | Universitaire Ziekenhuizen KU Leuven|KU Leuven | Inflammatory Bowel Diseases | 2022-02-08 | PHASE4 |
| NCT03819296 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Clinical Stage 0 Cutaneous Melanoma AJCC v8|Clinical Stage I Cutaneous Melanoma AJCC v8|Clinical Stage IA Cutaneous Melanoma AJCC v8|Clinical Stage IB Cutaneous Melanoma AJCC v8|Clinical Stage II Cutaneous Melanoma AJCC v8|Clinical Stage IIA Cutaneous Melanoma AJCC v8|Clinical Stage IIB Cutaneous Melanoma AJCC v8|Clinical Stage IIC Cutaneous Melanoma AJCC v8|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Colitis|Lung Non-Small Cell Carcinoma|Malignant Genitourinary System Neoplasm|Malignant Solid Neoplasm|Pathologic Stage 0 Cutaneous Melanoma AJCC v8|Pathologic Stage I Cutaneous Melanoma AJCC v8|Pathologic Stage IA Cutaneous Melanoma AJCC v8|Pathologic Stage IB Cutaneous Melanoma AJCC v8|Pathologic Stage II Cutaneous Melanoma AJCC v8|Pathologic Stage IIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIC Cutaneous Melanoma AJCC v8|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Stage 0 Lung Cancer AJCC v8|Stage I Lung Cancer AJCC v8|Stage IA1 Lung Cancer AJCC v8|Stage IA2 Lung Cancer AJCC v8|Stage IA3 Lung Cancer AJCC v8|Stage IB Lung Cancer AJCC v8|Stage II Lung Cancer AJCC v8|Stage IIA Lung Cancer AJCC v8|Stage IIB Lung Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8 | 2021-02-21 | PHASE1 |
| NCT01217086 | Celltrion | Rheumatoid Arthritis | 2010-10 | PHASE3 |
| NCT04272788 | Second Affiliated Hospital of Wenzhou Medical University | Crohn Disease | 2017-01-24 | |
| NCT01880307 | Erasmus Medical Center|University of Roma La Sapienza|Universitair Ziekenhuis Brussel | Crohn´s Disease | 2013-01 | PHASE4 |
| NCT07550673 | Xijing Hospital of Digestive Diseases | Acute Severe Ulcerative Colitis | 2026-04-20 | PHASE4 |
| NCT00591201 | Hospital General de Mexico|Schering-Plough | Spondylarthropathies | 2002-06 | PHASE2|PHASE3 |
| NCT00269841 | Centocor, Inc. | Crohn Disease | 1996-05 | PHASE3 |
| NCT07149441 | Shanghai 10th People´s Hospital | Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)|Fecal Microbiota Transplantation | 2025-08-01 | NA |
| NCT01144143 | Herbert Lindsley, MD|Centocor, Inc. | Osteoarthritis of the Knee | 2007-07 | PHASE4 |
| NCT03885089 | Pfizer | Psoriasis Vulgaris|Psoriasis Arthropathica|Pustular Psoriasis|Erythrodermic Psoriasis | 2019-10-21 | |
| NCT00714493 | Centocor Ortho Biotech Services, L.L.C.|Schering-Plough | Rheumatoid Arthritis | 2008-07 | PHASE4 |
| NCT05759104 | Central Hospital, Nancy, France | Crohn Disease | 2012-01-01 | |
| NCT07495644 | Assiut University | Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | 2026-03-01 | |
| NCT00056264 | Centocor, Inc. | Chronic Obstructive Pulmonary Disease|COPD | 2002-12 | PHASE3 |
| NCT00840957 | University Hospital, Tours | Rheumatoid Arthritis | 2007-11 | |
| NCT02293681 | Janssen Research & Development, LLC | Spondylitis, Ankylosing | 2015-04-10 | |
| NCT01610947 | University Hospital, Montpellier | Spondyloarthritis | 2012-05-14 | NA |
| NCT00507403 | University Hospital, Tours|Institut National de la Santé Et de la Recherche Médicale, France | Ankylosing Spondylitis | 2007-10 | PHASE4 |
| NCT02522169 | Klinikum Westbrandenburg GmbH | Pediatric Crohns Disease | 2015-09 | NA |
| NCT00271570 | University of California, San Diego|Centocor, Inc. | Kawasaki Disease | 2004-04 | PHASE1 |
| NCT01338740 | University Hospital, Ghent|Abbott | Crohn´s Disease | 2011-04 | |
| NCT02359903 | Biocad | Ankylosing Spondylitis | 2015-02 | PHASE1 |
| NCT01567358 | Nichi-Iko Pharmaceutical Co., Ltd. | Rheumatoid Arthritis | 2012-02 | PHASE1 |
| NCT00636142 | Medical University of Graz | Obesity|Insulin Resistance|Metabolic Syndrome | 2005-09 | PHASE4 |
| NCT01971970 | Erasmus Medical Center|Merck Sharp & Dohme LLC | Inflammatory Bowel Diseases | 2013-10 | |
| NCT03679546 | Rennes University Hospital | Ulcerative Colitis | 2019-01-04 | PHASE4 |
| NCT00462072 | University of Rochester|Centocor, Inc. | Rheumatoid Arthritis|Psoriatic Arthritis|Psoriasis|Crohn´s Disease | 2007-03 | PHASE4 |
| NCT02495077 | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation|Rho Federal Systems Division, Inc. | Kidney Transplant | 2015-11-02 | PHASE2 |
| NCT07470502 | Meyer Children´s Hospital IRCCS | IBD (Inflammatory Bowel Disease) | 2025-02-13 | NA |
| NCT00201799 | Ohio State University Comprehensive Cancer Center | Graft-Versus-Host Disease | 2004-02 | PHASE2 |
| NCT00537316 | Merck Sharp & Dohme LLC | Ulcerative Colitis | 2007-07 | PHASE3 |
| NCT05051137 | Karolinska Institutet|Harvard Medical School (HMS and HSDM) | Rheumatoid Arthritis | 2006-01-12 | |
| NCT03308357 | The Alfred|Merck Sharp & Dohme LLC | Inflammatory Bowel Diseases | 2017-10 | |
| NCT00732875 | Merck Sharp & Dohme LLC | Arthritis, Rheumatoid | 2006-08 | PHASE3 |
| NCT00725452 | Merck Sharp & Dohme LLC|Centocor, Inc. | Psoriasis | 2006-10 | |
| NCT05220280 | Clinical Urology and Epidemiology Working Group|University of Helsinki|World Health Organization|Helsinki University Central Hospital|Hyvink?? Hospital|Kanta-H?me Central Hospital|Kuopio University Hospital|City of Helsinki|Oulu University Hospital|Porvoo Hospital|Seinajoki Central Hospital|Mikkeli Central Hospital|Tampere University Hospital | Covid19|Coronavirus Disease 2019|SARS-CoV-2 Acute Respiratory Disease | 2022-02-06 | PHASE4 |
| NCT00372723 | Loyola University | Toxic Epidermal Necrolysis | 2006-07 | PHASE2 |
| NCT03192878 | Ospedale San Raffaele | Takayasu Arteritis | 2017-03-01 | |
| NCT04425538 | Tufts Medical Center|National Institutes of Health (NIH) | COVID-19 | 2020-06-01 | PHASE2 |
| NCT00228839 | Emory University | Graft vs Host Disease | | PHASE1 |
| NCT00794898 | Merck Sharp & Dohme LLC | Arthritis, Rheumatoid | 2003-07-01 | PHASE4 |
| NCT01571219 | Celltrion | Rheumatoid Arthritis | 2012-03 | PHASE3 |
| NCT00833053 | Merck Sharp & Dohme LLC | Psoriasis | 2009-10 | PHASE3 |
| NCT00779675 | Merck Sharp & Dohme LLC | Psoriasis | 2008-10 | |
| NCT00033891 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Dermatomyositis|Polymyositis | 2002-04-10 | PHASE2 |
| NCT03348046 | Hikma Pharmaceuticals LLC|Syneos Health | Rheumatoid Arthritis | 2017-03-23 | |
| NCT01592292 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-11 | |
| NCT07263477 | Second Affiliated Hospital of Wenzhou Medical University | Crohn Disease (CD) | 2020-01-01 | |
| NCT00443222 | Karolinska Institutet|Schering-Plough|Medical Research Council | Refractory Myositis | | PHASE2|PHASE3 |
| NCT01295151 | Julia Brown | Rheumatoid Arthritis | 2011-08 | PHASE4 |
| NCT00527072 | Centocor Ortho Biotech Services, L.L.C. | Psoriasis | 2007-07 | PHASE3 |
| NCT00725621 | Merck Sharp & Dohme LLC|Centocor, Inc. | Rheumatoid Arthritis | 2004-03 | |
| NCT00036439 | Centocor, Inc. | Ulcerative Colitis | 2002-02 | PHASE3 |
| NCT00687401 | Merck Sharp & Dohme LLC|Centocor, Inc. | Psoriasis | 2006-06 | PHASE3 |
| NCT01148901 | Merck Sharp & Dohme LLC|Hospital Universitario Reina Sofia de Cordoba|Dr. Jose María Martos Becerra (Central Radiological Assessment) - Hospital de Alta Resolución, Puente Genil (Spain) | Ankylosing Spondylitis | 2010-06 | PHASE4 |
| NCT02539368 | Pfizer|Hospira, now a wholly owned subsidiary of Pfizer | Inflammatory Bowel Diseases|Ulcerative Colitis|Crohn´s Disease | 2015-04-22 | |
| NCT06738719 | Celltrion | Moderately to Severely Active Rheumatoid Arthritis | 2025-01-03 | PHASE3 |
| NCT02605642 | Pfizer|Hospira, now a wholly owned subsidiary of Pfizer | Rheumatoid Diseases|Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis | 2015-09-10 | |
| NCT03446976 | Celltrion | Health, Subjective | 2018-02-21 | PHASE1 |
| NCT03707535 | Celltrion | Rheumatoid Arthritis | 2018-11-12 | PHASE3 |
| NCT03147248 | Celltrion | Rheumatoid Arthritis | 2016-09-12 | PHASE3 |
| NCT05719389 | IRCCS San Raffaele | Inflammatory Bowel Diseases|Rheumatologic Disease | 2022-09-14 | |
| NCT06274294 | CMC Ambroise Paré|Paris IBD Center|Celltrion HealthCare France | Inflammatory Bowel Diseases | 2024-07-10 | PHASE3 |
| NCT02883452 | Celltrion | Crohn´s Disease|Ulcerative Colitis (Part 2 Only) | 2016-09-29 | PHASE1 |
| NCT02096861 | Celltrion|Pfizer | Crohn´s Disease | 2014-09-19 | PHASE3 |
| NCT01872286 | Changhai Hospital|Second Military Medical University|Ministry of Education, China | Intestinal Diseases|Gastrointestinal Hemorrhage | 2011-11 | NA |
| NCT01922336 | Samsung Bioepis Co., Ltd. | Healthy | 2013-07 | PHASE1 |
| NCT01787825 | Capso Vision, Inc. | Intestinal Disease|Inflammatory Bowel Disease|Crohn Disease|Ulcer|Celiac Disease | 2012-05 | NA |
| NCT01085513 | Medtronic - MITG | Intestinal Abnormalities | 2009-02 | NA |
| NCT01532570 | Tanabe Pharma Corporation | Behcet´s Disease|Behcet Syndrome|Neuro-Behcet´s Disease | 2012-01 | PHASE3 |
| NCT01585155 | Tanabe Pharma Corporation | Pediatric Ulcerative Colitis | 2012-02 | PHASE3 |
| NCT00805766 | Tanabe Pharma Corporation | Crohn´s Disease | 2008-12 | PHASE3 |
| NCT01596335 | Tanabe Pharma Corporation | Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin | 2012-05 | PHASE3 |
| NCT01680159 | Tanabe Pharma Corporation | Plaque Psoriasis|Psoriatic Arthritis|Pustular Psoriasis (Excluding a Localized)|Psoriatic Erythroderma | 2012-07 | PHASE3 |
| NCT00691028 | Tanabe Pharma Corporation | Rheumatoid Arthritis | 2005-09 | PHASE3 |
| NCT01580670 | Tanabe Pharma Corporation | Pediatric Crohn´s Disease | 2012-03 | PHASE3 |